T2 Biosystems Announces Advances in Novel Hemostasis Direct Detection Program

Published: Apr 16, 2013

LEXINGTON, Mass.--(BUSINESS WIRE)--T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced advances in its hemostasis product development program for T2HemoStatâ„¢, which rapidly detects physical changes in a blood sample such as coagulation, fibrinolysis and platelet function, from small volumes of whole blood or plasma on a single, compact instrument.

Back to news